Amylyx Pharmaceuticals

ALS neurons brain synapses

Amylyx to pull failed ALS drug from market, cut 70% of staff

Amylyx is pulling the ALS drug Relyvrio from the U.S. and Canadian markets after a confirmatory trial failure.

Angus Liu Apr 4, 2024 10:06am

Image of a neon sign with the word no lit up next to an unlit yes

Amylyx's ALS drug Albrioza rebuffed by EU regulator—again

Oct 13, 2023 11:24am

launch

Amylyx's ALS drug Relyvrio continues to shine

Aug 11, 2023 11:32am

Chris Viehbacher

Biogen pays $7.3B to acquire Reata and newly approved Skyclarys

Jul 28, 2023 11:17am

Stamp with blue ink that says FDA Approved

Amylyx's ALS drug finally approved by FDA

Sep 29, 2022 5:00pm

Podcast

DNA

'The Top Line': Sarepta's DMD trial, Illumina's Grail quest

Sep 9, 2022 6:00am